Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Evoltra

This product is the most expensive of its product family


Contraindicated
Reproductive toxicity in animals

Contraindicated
Evoltra :
Type Medicine Authorised
Originator B
Agent Mersaco
Distributor Mersaco
Laboratory Genzyme Therapeutics
Responsible Party Genzyme Europe BV
Origin The Netherlands
Manufacturer Sanofi Winthrop Industrie
Origin France
ATC L01BB06

Your comment will appear shortly after approval

Evoltra :

Revision Date : 16/03/2015


Effect Frequency
Abdominal pain Common
Abdominal pain upper Common
Acute kidney injury Not known
Agitation Common
Alopecia Common
ALT increased Common
Amylase increased Not known
Anaemia Not known
Anxiety Very Common
Arthralgia (Pain joint) (Joint ache) Common
AST increased Common
Back pain Common
Bacteraemia Common
Bacterial infection Not known
Blood creatinine increased Not known
Bone marrow failure Not known
Bone pain Common
Capillary leak syndrome Common
Cerebral haemorrhage Not known
Chills Common
Cholecystitis acute Not known
Cholelithiasis (Calculus biliary) (Gallstones) Not known
Clostridium difficile colitis Not known
Colitis Not known
Contusion Common
Cough Common
Decreased appetite Common
Dehydration Common
Device related infection Not known
Diarrhoea (Diarrhea) Very Common
Dizziness Common
Dry skin Common
Dyspnoea (dyspnea) Common
Enterocolitis Not known
Epistaxis (Nasal bleeding) Common
Erythema Common
Fatigue Very Common
Febrile neutropenia (Neutropenic fever) Very Common
Feeling abnormal Common
Flushing Very Common
Fungal infection Not known
Gastroduodenal haemorrhage Not known
Generalized erythema Common
Gingival bleeding (Gingival hemorrhage) Common
Haematemesis Common
Haematoma Common
Haematuria (Hematuria) Common
Haemorrhage Not known
Hand and foot syndrome (Palmar-plantar erythrodysaesthesia syndrome) Very Common
Headache Very Common
Hepatocellular injury Not known
Herpes simplex Common
Herpes zoster Common
Hyperbilirubinaemia Common
Hyperhidrosis Common
Hypersensitivity Common
Hypoacusis Common
Hyponatraemia (Hyponatremia) Not known
Hypotension Common
Infection Not known
Irritability Common
Jaundice Common
Leucopenia (Leukopenia) Not known
Lipase increased Not known
Lyell Syndrome (Toxic epidermal necrolysis) Not known
Maculopapular rash Common
Mental status changes Common
Mouth haemorrhage Common
Mouth ulceration Common
Mucosal inflammation Very Common
Multi-organ failure Common
Musculoskeletal chest pain Common
Myalgia Common
Nausea Very Common
Neck pain Common
Neuropathy peripheral Common
Neutropenia Common
Neutropenic colitis Not known
Oedema Common
Oedema peripheral Common
Oral candidiasis Common
Pain Common
Pain in extremity (Pain in limb) Common
Pancreatitis Not known
Paraesthesia (paresthesia) Common
Pericardial effusion Common
Pericarditis Not known
Petechiae Common
Pneumonia Common
Proctalgia Common
Pruritus Very Common
Pulmonary haemorrhage Not known
Pyrexia Very Common
Rash erythematous Common
Rash generalised Common
Rash pruritic Common
Respiratory distress Common
Restlessness Common
Sensation of heat (Feeling of warmth) (Sensation of warmth) Common
Sepsis (Systemic infection) (Sepsis state) Common
Septic shock Common
Skin exfoliation (Flaking skin) Common
Skin hyperpigmentation Common
Somnolence Common
Stevens-Johnson syndrome Not known
Stomatitis Common
Systemic inflammatory response syndrome Common
Tachycardia Common
Tachypnoea Common
Thrombocytopenia (Thrombopenia) Not known
Tremor Common
Tumour lysis syndrome Common
Venoocclusive disease Common
Viral infection Not known
Vomiting Very Common
Weight decreased (Weight loss) Common

Different Units By MoH Code

Revision Date : 01/09/2015

Revision Date : 17/07/2015

Evoltra Evoltra Evoltra Evoltra Evoltra Evoltra

Evoltra  MoH 7266 :
Form Concentrate for solution for infusion
Packaging Bottle
Package Size 1x20ml
Strength 1mg/ml
Public Price 1499460 L.L.
Stratum E2
NSSF ✔
Quarantine ✘
Reg. Number 97675/11
Submission date 01/01/2011
Registration Year 2013


Price Comparison

● Country: Abu Dhabi
● Package Size: 1x20ml
● Public Price: 12689.1 AED ( 306,581,345.10 LBP )
● Pack size unit used: 1
● Cost/Unit: 12689,1 AED ( 306,578,929.00 LBP )
● Pharmacy Price: 11034 AED ( 266592474 LBP )
● Pricing Date: 27/01/2021
● Type: Medicine Authorised

● Country: Italy
● Package Size: 4x20ml
● Public Price: 9979.63 EUR ( 966,786,635.88 LBP )
● Pack size unit used: 4
● Cost/Unit: 2494,9075 EUR ( 241,608,744.00 LBP )
● Exfactory Price: 6046.75 EUR
● Pricing Date: 17/12/2019
● Type: Medicine Authorised

● Country: Finland
● Package Size: 1x20ml
● Public Price: 2067.07 EUR ( 200,249,473.32 LBP )
● Pack size unit used: 1
● Cost/Unit: 2067,07 EUR ( 200,242,692.00 LBP )
● Reference: Kela
● Pricing Date: 22/04/2021
● Type: Medicine Authorised

● Country: The Netherlands
● Package Size: 1x20ml
● Public Price: 1814.75 EUR ( 175,805,721.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 1814,75 EUR ( 175,733,064.00 LBP )
● Pharmacy Price: 1807.75 EUR ( 175127589 LBP )
● Reference: Zorginstituut Nederland
● Pricing Date: 15/06/2019
● Type: Medicine Authorised

● Country: Denmark
● Package Size: 1x20ml
● Public Price: 13284 DKK ( 172,373,184.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 13284 DKK ( 172,373,184.00 LBP )
● Pharmacy Price: 9871.49 DKK ( 128092454.24 LBP )
● Reference: Danish Medicine Agency
● Pricing Date: 19/05/2021
● Type: Medicine Authorised

● Country: Spain
● Package Size: 1x20ml
● Public Price: 1722.19 EUR ( 166,838,878.44 LBP )
● Pack size unit used: 1
● Cost/Unit: 1722,19 EUR ( 166,820,472.00 LBP )
● Reference: Agencia Española de Medicamentos y Productos Sanitarios
● Pricing Date: 06/05/2021
● Type: Medicine Authorised

● Country: UK
● Package Size: 1x20ml
● Public Price: 1326.18 GBP ( 150,719,030.82 LBP )
● Pack size unit used: 1
● Cost/Unit: 1326,18 GBP ( 150,698,574.00 LBP )
● Reference: DMD
● Pricing Date: 08/03/2021
● Type: Medicine Authorised

● Country: Belgium
● Package Size: 1x20ml
● Public Price: 1425 EUR ( 138,048,300.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 1425 EUR ( 138,048,300.00 LBP )
● Reference: cbip
● Pricing Date: 02/12/2020
● Type: Medicine Authorised

● Country: Norway
● Package Size: 1x20ml
● Public Price: 16817.8 NOK ( 136,291,451.20 LBP )
● Pack size unit used: 1
● Cost/Unit: 16817,8 NOK ( 136,284,968.00 LBP )
● Pharmacy Price: 13162.02 NOK ( 106665010.08 LBP )
● Reference: Norwegian Medicine Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

● Country: Cyprus
● Package Size: 20ml
● Public Price: 1360.24 EUR ( 131,774,610.24 LBP )
● Pack size unit used: 1
● Cost/Unit: 1360,24 EUR ( 131,751,360.00 LBP )
● Reference: Cyprus Minister of Health
● Pricing Date: 24/03/2021
● Type: Medicine Authorised

● Country: Greece
● Package Size: 1x20ml
● Public Price: 1325.41 EUR ( 128,400,419.16 LBP )
● Pack size unit used: 1
● Cost/Unit: 1325,41 EUR ( 128,360,700.00 LBP )
● Exfactory Price: 1173.25 EUR
● Pharmacy Price: 1190.85 EUR ( 115364784.6 LBP )
● Reference: National Organization for Medicines
● Pricing Date: 25/02/2021
● Type: Medicine Authorised

● Country: Lebanon
● Form: Concentrate for solution for infusion
● Package Size: 1x20ml
● Public Price: 1499460 LBP ( 1,499,460.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 1499460 LBP ( 1,499,460.00 LBP )
● Pricing Date: 13/06/2024

● Country: Portugal
● Package Size: 1x20ml
● Reference: Autoridade Nacional do Medicamento e Produtos de Saúde
● Pricing Date: 22/04/2019

● Country: France
● Package Size: 1x20ml
● Reference: ansm
● Pricing Date: 15/05/2021
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Acute lymphoblastic leukaemia :
● Cost/Unit: 12689,1 AED ( 306,578,929.00 LBP )
● Cost/Day: 50756,4 AED ( 1,226,315,716.00 LBP )
● Cost/Month: 1522692 AED ( 36,789,761,412.00 LBP )
Acute lymphoblastic leukaemia :
● Cost/Unit: 2494,9075 EUR ( 241,608,744.00 LBP )
● Cost/Day: 9979,63 EUR ( 966,725,604.00 LBP )
● Cost/Month: 299388,9 EUR ( 29,003,511,888.00 LBP )
Acute lymphoblastic leukaemia :
● Cost/Unit: 2067,07 EUR ( 200,242,692.00 LBP )
● Cost/Day: 8268,28 EUR ( 800,970,768.00 LBP )
● Cost/Month: 248048,4 EUR ( 24,029,898,048.00 LBP )
Acute lymphoblastic leukaemia :
● Cost/Unit: 1814,75 EUR ( 175,733,064.00 LBP )
● Cost/Day: 7259 EUR ( 703,222,884.00 LBP )
● Cost/Month: 217770 EUR ( 21,096,686,520.00 LBP )
Acute lymphoblastic leukaemia :
● Cost/Unit: 13284 DKK ( 172,373,184.00 LBP )
● Cost/Day: 53136 DKK ( 689,492,736.00 LBP )
● Cost/Month: 1594080 DKK ( 20,684,782,080.00 LBP )
Acute lymphoblastic leukaemia :
● Cost/Unit: 1722,19 EUR ( 166,820,472.00 LBP )
● Cost/Day: 6888,76 EUR ( 667,281,888.00 LBP )
● Cost/Month: 206662,8 EUR ( 20,020,587,912.00 LBP )
Acute lymphoblastic leukaemia :
● Cost/Unit: 1326,18 GBP ( 150,698,574.00 LBP )
● Cost/Day: 5304,72 GBP ( 602,794,296.00 LBP )
● Cost/Month: 159141,6 GBP ( 18,086,215,509.00 LBP )
Acute lymphoblastic leukaemia :
● Cost/Unit: 1425 EUR ( 138,048,300.00 LBP )
● Cost/Day: 5700 EUR ( 552,193,200.00 LBP )
● Cost/Month: 171000 EUR ( 16,565,796,000.00 LBP )
Acute lymphoblastic leukaemia :
● Cost/Unit: 16817,8 NOK ( 136,284,968.00 LBP )
● Cost/Day: 67271,2 NOK ( 545,164,184.00 LBP )
● Cost/Month: 2018136 NOK ( 16,354,974,144.00 LBP )
Acute lymphoblastic leukaemia :
● Cost/Unit: 1360,24 EUR ( 131,751,360.00 LBP )
● Cost/Day: 5440,96 EUR ( 527,005,440.00 LBP )
● Cost/Month: 163228,8 EUR ( 15,812,875,728.00 LBP )
Acute lymphoblastic leukaemia :
● Cost/Unit: 1325,41 EUR ( 128,360,700.00 LBP )
● Cost/Day: 5301,64 EUR ( 513,539,676.00 LBP )
● Cost/Month: 159049,2 EUR ( 15,408,030,924.00 LBP )
Acute lymphoblastic leukaemia :
● Cost/Unit: 1499460 LBP ( 1,499,460.00 LBP )
● Cost/Day: 5997840 LBP ( 5,997,840.00 LBP )
● Cost/Month: 179935200 LBP ( 179,935,200.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info